A core activity in so many areas like medicine, life science, pharmaceuticals – in clinical, industrial and research settings – in vitro diagnostics (IVD) is a major market with big technological and commercial prospects and is forecast to grow at a CAGR of 6.55 percent over the period 2011-2015. The main growth drivers are the increasing demand for biomarker-based tests worldwide and an increased adoption of DNA probe-based diagnostics.
Our wealth of detailed and insightful reports covers
a wide variety of topics within the IVD sphere; these include immunochemistry, molecular diagnostics, point-of-care testing, microbiology, hematology, immunoassays and infectious immunology.
Make your move based on the latest knowledge and data in this dynamic field by keeping track of investment opportunities, scientific developments, new products and technologies, market shares, key players and much more.
Hundreds of companies operating in today’s market are featured in our publications, including top global players such as Abbott Laboratories, bioMerieux SA, Beckman Coulter, Becton Dickinson and Company, Hoffmann-La Roche, and Siemens Healthcare, as well as niche players and new, fast-growing companies.